Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |